These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

716 related articles for article (PubMed ID: 24830878)

  • 1. Electronic monitoring to assess adherence with once-daily glaucoma medications and risk factors for nonadherence: the automated dosing reminder study.
    Boland MV; Chang DS; Frazier T; Plyler R; Friedman DS
    JAMA Ophthalmol; 2014 Jul; 132(7):838-44. PubMed ID: 24830878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated telecommunication-based reminders and adherence with once-daily glaucoma medication dosing: the automated dosing reminder study.
    Boland MV; Chang DS; Frazier T; Plyler R; Jefferys JL; Friedman DS
    JAMA Ophthalmol; 2014 Jul; 132(7):845-50. PubMed ID: 24831037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma.
    Friedman DS; Okeke CO; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Quigley HA
    Ophthalmology; 2009 Jun; 116(6):1097-105. PubMed ID: 19376591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study.
    Okeke CO; Quigley HA; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Friedman DS
    Ophthalmology; 2009 Feb; 116(2):191-9. PubMed ID: 19084273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of medication adherence to topical glaucoma therapy.
    Dreer LE; Girkin C; Mansberger SL
    J Glaucoma; 2012; 21(4):234-40. PubMed ID: 21623223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a predictive model for nonadherence with once-daily glaucoma medications.
    Chang DS; Friedman DS; Frazier T; Plyler R; Boland MV
    Ophthalmology; 2013 Jul; 120(7):1396-402. PubMed ID: 23541760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of adherence to brimonidine therapy for glaucoma using electronic monitoring.
    Hermann MM; Bron AM; Creuzot-Garcher CP; Diestelhorst M
    J Glaucoma; 2011 Oct; 20(8):502-8. PubMed ID: 20852438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intentional and unintentional nonadherence to ocular hypotensive treatment in patients with glaucoma.
    Rees G; Leong O; Crowston JG; Lamoureux EL
    Ophthalmology; 2010 May; 117(5):903-8. PubMed ID: 20153902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use.
    Robin AL; Novack GD; Covert DW; Crockett RS; Marcic TS
    Am J Ophthalmol; 2007 Oct; 144(4):533-40. PubMed ID: 17686450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of Patient-reported Adherence to Glaucoma Medications on a Visual Analog Scale Compared With Electronic Monitors.
    Sayner R; Carpenter DM; Blalock SJ; Robin AL; Muir KW; Hartnett ME; Giangiacomo AL; Tudor G; Sleath B
    Clin Ther; 2015 Sep; 37(9):1975-85. PubMed ID: 26164785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personality traits, depression, and objectively measured adherence to once-daily prostaglandin analog medication in glaucoma.
    Holló G; Kóthy P; Géczy A; Vargha P
    J Glaucoma; 2009; 18(4):288-92. PubMed ID: 19365193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morning dosing of once-daily glaucoma medication is more convenient and may lead to greater adherence than evening dosing.
    Ford BA; Gooi M; Carlsson A; Crichton AC
    J Glaucoma; 2013 Jan; 22(1):1-4. PubMed ID: 21946541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparisons of Self-reported Glaucoma Medication Adherence With a New Wireless Device: A Pilot Study.
    Gatwood JD; Johnson J; Jerkins B
    J Glaucoma; 2017 Nov; 26(11):1056-1061. PubMed ID: 29099436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Affecting Adherence to Topical Glaucoma Therapy: A Quantitative and Qualitative Pilot Study Analysis in Sydney, Australia.
    Spencer SKR; Shulruf B; McPherson ZE; Zhang H; Lee MB; Francis IC; Bank A; Coroneo MT; Agar A
    Ophthalmol Glaucoma; 2019; 2(2):86-93. PubMed ID: 32672609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Most Common Barriers to Glaucoma Medication Adherence: A Cross-Sectional Survey.
    Newman-Casey PA; Robin AL; Blachley T; Farris K; Heisler M; Resnicow K; Lee PP
    Ophthalmology; 2015 Jul; 122(7):1308-16. PubMed ID: 25912144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the introduction of generic latanoprost on glaucoma medication adherence.
    Stein JD; Shekhawat N; Talwar N; Balkrishnan R
    Ophthalmology; 2015 Apr; 122(4):738-47. PubMed ID: 25680226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and correlates of self-reported nonadherence with eye drop treatment: the Belgian Compliance Study in Ophthalmology (BCSO).
    Vandenbroeck S; De Geest S; Dobbels F; Fieuws S; Stalmans I; Zeyen T
    J Glaucoma; 2011 Sep; 20(7):414-21. PubMed ID: 21048510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive perspective on patient adherence to topical glaucoma therapy.
    Tsai JC
    Ophthalmology; 2009 Nov; 116(11 Suppl):S30-6. PubMed ID: 19837258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventions improve poor adherence with once daily glaucoma medications in electronically monitored patients.
    Okeke CO; Quigley HA; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Friedman DS
    Ophthalmology; 2009 Dec; 116(12):2286-93. PubMed ID: 19815286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of an Electronic Health Record-Linked Glaucoma Medical Reminder With Patient Satisfaction.
    Varadaraj V; Friedman DS; Boland MV
    JAMA Ophthalmol; 2019 Mar; 137(3):240-245. PubMed ID: 30543342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.